The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.
Cyclophilin D, a target for counteracting skeletal muscle dysfunction in mitochondrial myopathy
Open accessAbstract
Muscle weakness and exercise intolerance are hallmark symptoms in mitochondrial disorders. Little is known about the mechanisms leading to impaired skeletal muscle function and ultimately muscle weakness in these patients. In a mouse model of lethal mitochondrial myopathy, the muscle-specific Tfam knock-out (KO) mouse, we previously demonstrated an excessive mitochondrial Ca(2+) uptake in isolated muscle fibers that could be inhibited by the cyclophilin D (CypD) inhibitor, cyclosporine A (CsA). Here we show that the Tfam KO mice have increased CypD levels, and we demonstrate that this increase is a common feature in patients with mitochondrial myopathy. We tested the effect of CsA treatment on Tfam KO mice during the transition from a mild to terminal myopathy. CsA treatment counteracted the development of muscle weakness and improved muscle fiber Ca(2+) handling. Importantly, CsA treatment prolonged the lifespan of these muscle-specific Tfam KO mice. These results demonstrate that CsA treatment is an efficient therapeutic strategy to slow the development of severe mitochondrial myopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Experiments conducted in isolated whole muscles and intact single muscle fibers of Tfam KO mice aged 12-14 weeks have shown muscle weakness (i.e. lower muscle force production) associated with a prolonged and excessive mitochondrial calcium (Ca2+) accumulation (Aydin et al., 2009; Gineste et al., 2015).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Gineste et al., 2015
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Tfam KO mice do not live more than ∼20 weeks and appear healthy until 12-14 weeks, at which point a progressive clinical phenotype becomes evident (Gineste et al., 2015; Wredenberg et al., 2002).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Gineste et al., 2015
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“These results extend those from previous studies showing severe muscle weakness in more advanced stages of the disease (Gineste et al., 2015; Wredenberg et al., 2002), and support those reported in patients related to a progression from early premature fatigue to disabling muscle weakness at rest (Finsterer, 2020; Tarnopolsky, 2016).”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Gineste et al., 2015
The cited source says what the claim attributes to it.
In the citing paper
“the MAM-related matrix protein cyclophilin D (also called peptidyl-prolyl cis-trans isomerase F) is involved in excessive Ca2+ uptake”
From Impaired aerobic capacity and premature fatigue preceding muscle weakness in the skeletal muscle Tfam-knockout mouse model (2021) · cites this paper as Gineste et al., 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes
Liu, J., Farmer, J. D., Lane, W. S., Friedman, J., Weissman, I., & Schreiber, S. L. (1991) · Cell · doi:10.1016/0092-8674(91)90124-h · Cited by 4,116
Calcium, ATP, and ROS: a mitochondrial love-hate triangle
Brookes, P. S., Yoon, Y., Robotham, J. L., Anders, M. W., & Sheu, S.-S. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00139.2004 · Cited by 2,575
A forty-kilodalton protein of the inner membrane is the mitochondrial calcium uniporter
De Stefani, D., Raffaello, A., Teardo, E., Szabò, I., & Rizzuto, R. (2011) · Nature · doi:10.1038/nature10230 · Cited by 1,915
Integrative genomics identifies MCU as an essential component of the mitochondrial calcium uniporter
Baughman, J. M., Perocchi, F., Girgis, H. S., Plovanich, M., Belcher-Timme, C. A., Sancak, Y., Bao, X. R., Strittmatter, L., Goldberger, O., Bogorad, R. L., et al. (2011) · Nature · doi:10.1038/nature10234 · Cited by 1,906
Mitochondrial DNA mutations in human disease
Taylor, R. W., & Turnbull, D. M. (2005) · Nature Reviews Genetics · doi:10.1038/nrg1606 · Cited by 1,852
Mitochondria as sensors and regulators of calcium signalling
Rizzuto, R., De Stefani, D., Raffaello, A., & Mammucari, C. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3412 · Cited by 1,781
Chaperone-mediated coupling of endoplasmic reticulum and mitochondrial Ca2+ channels
Szabadkai, G., Bianchi, K., Várnai, P., De Stefani, D., Wieckowski, M. R., Cavagna, D., Nagy, A. I., Balla, T., & Rizzuto, R. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200608073 · Cited by 1,413
Mitochondria and calcium: from cell signalling to cell death
Duchen, M. R. (2000) · The Journal of Physiology · doi:10.1111/j.1469-7793.2000.00057.x · Cited by 1,259
The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore
Kokoszka, J. E., Waymire, K. G., Levy, S. E., Sligh, J. E., Cai, J., Jones, D. P., MacGregor, G. R., & Wallace, D. C. (2004) · Nature · doi:10.1038/nature02229 · Cited by 1,086
MICU1 encodes a mitochondrial EF hand protein required for Ca2+ uptake
Perocchi, F., Gohil, V. M., Girgis, H. S., Bao, X. R., McCombs, J. E., Palmer, A. E., & Mootha, V. K. (2010) · Nature · doi:10.1038/nature09358 · Cited by 881
Cited by
Cheng, A. J., Place, N., & Westerblad, H. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a029710 · Cited by 161
Self-citationRueda, C. B., Llorente‐Folch, I., Traba, J., Amigo, I., González‐Sánchez, P., Contreras, L., Juaristi, I., Martínez-Valero, P., Pardo, B., del Arco, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.04.003 · Cited by 112
Basse, A. L., Agerholm, M., Farup, J., Dalbram, E., Nielsen, J., Ørtenblad, N., Altıntaş, A., Ehrlich, A. M., Krag, T. O. B., Bruzzone, S., et al. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101271 · Cited by 65
Intracellular to Interorgan Mitochondrial Communication in Striated Muscle in Health and Disease
Boardman, N. T., Trani, G., Scalabrin, M., Romanello, V., & Wüst, R. C. I. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad004 · Cited by 53
Cheng, A. J., & Westerblad, H. (2017) · Nature Protocols · doi:10.1038/nprot.2017.056 · Cited by 47
Self-citation
Metadata
- Authors
- Gineste, C., Hernandez, A., Ivarsson, N., Cheng, A. J., Naess, K., Wibom, R., Lesko, N., Bruhn, H., Wedell, A., Freyer, C., Zhang, S.-J., Carlström, M., Lanner, J. T., Andersson, D. C., Bruton, J. D., Wredenberg, A., & Westerblad, H.
- Affiliations
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Corresponding author
- Wredenberg, Anna
- Westerblad, Håkan
- ORCID
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-09-14
- Volume
- 24
- Issue
- 23
- Pages
- 6580-6587
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- PMC
- PMC4634369
- OpenAlex
- W1946613025
- Cited by
- 21
- References
- 41
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 3 · 2019: 1 · 2018: 2 · 2017: 4 · 2016: 4 · 2015: 1
- FWCI
- 1.59
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Human Molecular Genetics (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Swedish Research Council
- Stockholm County Council (SLL20130090)
- Swedish National Center for Sports Research, Association Française contre les Myopathies
- The National Institute of Arthritis and Musculoskeletal
- Skin Diseases of the National Institutes of Health (1F32AR057619)
- National Institutes of Health
- Swedish Foundation for Strategic Research (SSF)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- cyclophilin D, cyclosporine, mitochondrial myopathy, skeletal muscle dysfunction, muscle weakness, exercise intolerance, mitochondrial calcium uptake, calcium handling, lifespan extension
- MeSH terms
- Peptidyl-Prolyl Isomerase F, Animals, Calcium, Disease Models, Animal, DNA, Mitochondrial, Gene Expression Regulation, Humans, Mitochondria, Mutation, Cyclosporine, Mitochondrial Myopathies, Mice, Knockout, Muscle, Skeletal, Cyclophilins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cyclophilin D, a target for counteracting skeletal muscle dysfunction in mitochondrial myopathy. https://app.cochat.ai/papers/10.1093/hmg/ddv361
- The paper
- Gineste, C., Hernandez, A., Ivarsson, N., Cheng, A. J., Naess, K., Wibom, R., Lesko, N., Bruhn, H., Wedell, A., Freyer, C., Zhang, S.-J., Carlström, M., Lanner, J. T., Andersson, D. C., Bruton, J. D., Wredenberg, A., & Westerblad, H. (2015). Cyclophilin D, a target for counteracting skeletal muscle dysfunction in mitochondrial myopathy. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddv361
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.